PAAMCP
CRL icon

Pacific Alternative Asset Management Company (PAAMCO)’s Charles River Laboratories CRL Stock Holding History

Pacific Alternative Asset Management Company (PAAMCO)’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-12,546
Closed -$749K – 125
2014
Q3 		$749K Buy
12,546
+478
+4% +$27.3K 0.08% 162
2014
Q2 		$646K Buy
12,068
+2,052
+20% +$113K 0.08% 156
2014
Q1 		$604K Buy
10,016
+234
+2% +$13.6K 0.1% 114
2013
Q4 		$519K Buy
+9,782
New +$491K 0.18% 71

Other funds holding CRL

ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
FC
Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Pacific Alternative Asset Management Company (PAAMCO)'s CRL Position: Q4 2014 in Review

Pacific Alternative Asset Management Company (PAAMCO) sold out of Charles River Laboratories (CRL) in Q4 2014, closing a stake of 12,546 shares — an estimated $749K sold.

Pacific Alternative Asset Management Company (PAAMCO) first reported a position in CRL in Q4 2013 and held it in 4 quarters. The position peaked at $749K in Q3 2014. 252 funds tracked by Wall St. Rank hold CRL as of Q4 2014.

  • Pacific Alternative Asset Management Company (PAAMCO) reported no remaining Charles River Laboratories position as of Q4 2014 after selling out during the quarter.
  • Pacific Alternative Asset Management Company (PAAMCO) sold 12,546 Charles River Laboratories shares in Q4 2014, an estimated $749K.
  • Pacific Alternative Asset Management Company (PAAMCO) first reported a position in Charles River Laboratories in Q4 2013 and held it in 4 quarters.
  • Pacific Alternative Asset Management Company (PAAMCO)'s Charles River Laboratories position peaked at $749K in Q3 2014.
  • 252 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2014.

Based on Pacific Alternative Asset Management Company (PAAMCO)'s 13F filing for Q4 2014, filed 13 Feb 2015.